CIK 0001347178
- Accelerated filer
Vanda Pharmaceuticals Inc.
Sign in to watch- Ticker
- VNDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 030491827
- Phone
- +1 202-734-3400
- Business address
- 2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion SVP & Cheif Commercial Officer acquired 15,000 shares (option exercise)
- 4 Shares withheld for taxes President and CEO gave up 16,836 shares (to pay taxes)
- 4 Shares withheld for taxes SVP, CFO, Sec & Treasurer gave up 6,978 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4/A Open-market sale SVP & Chief Medical Officer sold 4,760 shares at $4.65 ($22,152)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale President and CEO sold 11,350 shares at $4.69 ($53,254)
- 4 Open-market sale SVP, CFO, Sec & Treasurer sold 4,920 shares at $4.67 ($22,994)
Page 16 of 29 · 579 filings